NCT00213733已完成不适用
Research of Molecular Markers for Diagnosis and/or Prognosis in Lymph Node Metastasis of Resected Non-small Cell Lung Cancer
University Hospital, Strasbourg, France5 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2004年6月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
- 试验地点
- 5
研究概览
简要总结
This is a prospective study of surgically resected samples and lymph nodes of lung cancer patients. For histopathologically positive lymph nodes from a complete resection, the investigators would like to analyse tumor tissue by allelotyping and comparing these results with those observed in the primary lung tumor to establish a cartography of molecular alteration in resected lung cancer. For non histopathologically positive lymph nodes, the investigators would like to research the presence (or not) of micrometastasis by allele-specific PCR (polymerase chain reaction).
详细描述
Genetic: It is a prospective study during two years with three years for follow-up. No control group is recruited.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with resectable non-small cell lung cancer (stage I to IIIA), with a complete resection of the tumor and paired lymph nodes.
- •Informed consent is required.
排除标准
- •Another cancer
- •Chemotherapy before surgical treatment
研究者
研究点 (5)
Loading locations...
相似试验
已完成
不适用
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsLung CancerNCT00899028Vanderbilt University Medical Center689
已完成
不适用
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung CancerLung CancerNCT00897650Vanderbilt-Ingram Cancer Center204
Unknown
不适用
Molecular Profiling in Small Cell Lung CancerLung NeoplasmsSmall Cell Lung CancerNCT03162705Zhujiang Hospital120
已完成
不适用
Biomarkers for Diagnosis of Lung CancerLung CancerLung NeoplasmNCT02050100SK Medical (Beijing) Co., Ltd.300
已完成
Unknown
ongmerkerstudieNL-OMON26180Catharina Ziekenhuis Eindhoven, NWO, Catharina Onderzoeksfonds, Roche Diagnostics Nederland1,500
